Twist Bio To Pay $22.5M To End Agilent Trade Secrets Suit
Biotech startup Twist Bioscience Corp. has agreed to shell out $22.5 million to put to rest a yearslong dispute with Agilent Technologies Inc. over proprietary DNA synthesis technology, the companies said...To view the full article, register now.
Already a subscriber? Click here to view full article